GlobalData on MSN
FDA grants accelerated approval for Otsuka’s IgAN therapy
Otsuka Pharmaceutical has accelerated FDA approval for Voyxact to reduce proteinuria in adults with primary IgAN at disease ...
Results of a prospective cohort study suggest history of gestational diabetes (GD) may promote development of atherosclerotic plaque, potentially increasing the risk of future heart disease among ...
Below is Validea's guru fundamental report for GENERAL DYNAMICS CORP (GD). Of the 22 guru strategies we follow, GD rates highest using our Multi-Factor Investor model based on the published strategy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback